| | Biological agents | Rituximab | | Ocrelizumab | | Belimumab | | Epratuzumab | | Atacicept | | Tocilizumab | | Infliximab | | Abatacept |
| | Anticytokine therapies | Anti-TNFα | | Anti-IFNy | | Anti-interleukin 10 | | Anti-interleukin 6 receptor | | Anti-interleukin 1 receptor | | Anti- IFNα |
| | Other techniques | Immunoadsorption | | Anti-C5a | | Peptide therapies | | T cell vaccination | | Costimulation inhibition with anti-CD154 | | B cell anergy with abetimus |
|
|